Nebula Research & Development LLC

SEC CIK: 0001792635
Latest filing: May 15, 2026

SEC filings (opens in a new tab)

LGND holding history

Ligand Pharmaceuticals Inc in every 13F filed by Nebula Research & Development LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LGND overview All 13F holders of LGND Full Q1 2026 holdings

Shares (Q2 2024): 0; Sold out in Q2 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2023

Holdings of LGND by Nebula Research & Development LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2024	0	$0	0.0%	−6,300−100.0%	Sold out	Holders
Q1 2024	6,300	$460.5K	0.1%	+6,300	New	Holders
Q4 2023	0	$0	0.0%	−5,379−100.0%	Sold out	Holders
Q3 2023	5,379	$322.3K	0.2%	+5,379	New	Holders